Valuation: IRADIMED CORPORATION

Market Cap 1.12B 957M 893M 819M 1.54B 107B 1.57B 10.59B 4.13B 53.59B 4.2B 4.1B 177B P/E 2026 *
45.5x
P/E 2027 * 39.4x
Enterprise Value 1.12B 957M 893M 819M 1.54B 107B 1.57B 10.59B 4.13B 53.59B 4.2B 4.1B 177B EV / Sales 2026 *
12.3x
EV / Sales 2027 * 11.1x
Free-Float
64.81%
Yield 2026 *
-
Yield 2027 * -
1 day+0.55%
1 week+0.78%
Current month-3.32%
1 month-9.47%
3 months-2.83%
6 months-15.18%
Current year-9.70%
1 week 85
Extreme 85
89.03
1 month 85
Extreme 85
97.74
Current year 76.95
Extreme 76.95
107.9
1 year 67.84
Extreme 67.8421
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 28/05/2020
Director of Finance/CFO 64 20/06/2022
Chief Tech/Sci/R&D Officer - 01/01/2020
Director TitleAgeSince
Chairman 72 16/06/2020
Director/Board Member 70 01/01/2019
Director/Board Member 73 01/01/2014
Date Insider Type Main position Quantity % Market Cap.
30/3/26 Sell

Chief Executive Officer

7,500 0.0590%
13/2/26 Sell

Director

1,000 0.0079%
26/1/26 Sell

Chief Executive Officer

5,000 0.0393%
Change 5-day change 1-year change 3-year change Capi.($)
+0.58%+0.78%+25.81%+83.34% 1.12B
+1.23%-0.46%-15.10%-16.18% 13.19B
+2.72%+4.66%+25.94%+14.90% 4.48B
+3.66%-0.29%-40.17%-50.51% 1.26B
-0.83%-2.18%-36.22% - 1.15B
+5.97%-0.26%-35.06%-34.99% 1.14B
+3.90%-12.16%+45.96%+134.53% 539M
-0.16%-10.60%+54.06% - 306M
-0.51%+2.46%-62.12%+286.80% 264M
-1.30%-9.22%+27.58%-11.33% 168M
Average +1.44%-2.07%-0.93%+50.82% 2.36B
Weighted average by Cap. +1.73%+0.68%-6.64%-0.48%

Financials

2026 *2027 *
Net sales 91.2M 78.09M 72.86M 66.85M 126M 8.73B 128M 864M 337M 4.37B 342M 335M 14.48B 101M 86.48M 80.68M 74.04M 139M 9.66B 142M 957M 373M 4.84B 379M 371M 16.03B
Net income 24.65M 21.11M 19.69M 18.07M 33.95M 2.36B 34.62M 234M 91.06M 1.18B 92.56M 90.54M 3.91B 28.45M 24.36M 22.73M 20.85M 39.19M 2.72B 39.96M 270M 105M 1.36B 107M 104M 4.52B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
21/08/26 USD 87.84 +0.50% 34,038
19/08/26 USD 87.40 -0.17% 100,863
18/08/26 USD 87.55 -0.53% 66,903
17/08/26 USD 88.02 +1.23% 106,373
14/08/26 USD 86.95 -0.24% 142,684
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
87.40USD
Average target price
118.00USD
Spread / Average Target
+35.01%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock